Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection by M. P. Snee et al.
ERRATUM Open Access
Erratum to: The SABRTooth feasibility trial
protocol: a study to determine the
feasibility and acceptability of conducting a
phase III randomised controlled trial
comparing stereotactic ablative
radiotherapy (SABR) with surgery in
patients with peripheral stage I non-small
cell lung cancer (NSCLC) considered to be
at higher risk of complications from
surgical resection
M. P. Snee1, L. McParland2, F. Collinson2, C. M. Lowe2, A. Striha2, D. R. Baldwin3, B. Naidu4, D. Sebag-Montefiore1,6,
W. M. Gregory2, J. Bestall5, J. Hewison5, S. Hinsley2 and K. N. Franks1*
Erratum
After publication of the original article [1], it came to
the authors’ attention that a source of funding had been
inadvertently omitted from the Acknowledgements
section; support from Yorkshire Cancer Research should
have mentioned originally.
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